roy@gitpyr.UUCP (Roy Mongiovi) (11/24/85)
Can anyone give me some information about any of the following substances? I've seen ads for some of them and heard vague promises about others, does anyone have any real info? 1) Coenzyme Q-10 2) N,N Dimethylglycine 3) Octocosanol 4) Superoxide Dismutase I mean, what ARE these things? Roy -- Roy J. Mongiovi. Office of Computing Services. User Services. Georgia Institute of Technology. Atlanta GA 30332. (404) 894-6163 ...!{akgua, allegra, amd, hplabs, ihnp4, masscomp, ut-ngp}!gatech!gitpyr!roy
werner@aecom.UUCP (12/03/85)
> Can anyone give me some information about any of the following > substances? I've seen ads for some of them and heard vague > promises about others, does anyone have any real info? > > 1) Coenzyme Q-10 Also known as CoenzymeQ (the 10 refers to a chain length of a tail, which is actually variable. It is also called Ubiquinone - since it is a Quinone - and it is ubiquitous in nature. It is the first step in the electron transport chain in all cells - plant or animal or bacteria, and hence essential for all energy utilization. Since everything you eat is either plant or animal, your diet is chock full of it, so to use a supplement is of dubious value at best, but it is all the rage for food faddists.... > 4) Superoxide Dismutase This converts Superoxide radicals (the fiendish Free Radicals that will age you, cause all known diseases, including cancer, and lose the war for the Allies) into Hydrogen Peroxide, which is then converted by Catalase to harmless water. It is incidentally needed by the Immune system (Neutrophils) but it is produced endogenously, and besides, as a protein, would never make it past the stomach anyway if taken by mouth. The other two - I never heard of, either. > > I mean, what ARE these things? > Roy -- Craig Werner !philabs!aecom!werner "It's tough to incriminate a bread mold."
wurzelma@aecom.UUCP (John Wurzelmann) (12/03/85)
As luck would have it, I am currently involved in the clinical testing of Coenzyme Q-10 for the treatment of angina pectoris. Our trials are still in progress and still double-blinded, so it's impossible to say anything concrete about the efficacy of this medication, but I must say that it is the gut feeling of those of us who are involved that the drug will not pan out as a useful treatment for angina. On the other hand, the drug has apparently done well in clinical trials in Japan. A review on this subject is currently being written by Drs. William Frishman, Steven Greenberg and David Jacobs, and should be appearing in Cardiovascular Reviews and Reports sometime early next year. For the time being however, I would not recommend that anyone take this medication for any reason. John Wurzelmann